25. Intra‐ocular pressure ‐ Studies undertaking multivariable regression analyses to determine the effect of intra‐ocular pressure at baseline on progression to PDR.
Study | Study type | Time years | N at baseline | Adjustment factors | Effect estimate | P value | Comments | ||
Type | Value | 95% CI | |||||||
Type 1 diabetes | |||||||||
WESDR Moss 1993 |
Prospective cohort | 4 | 996 | HbA1c, DR severity, and age at baseline. | OR | 1.04 | 0.96 to 1.13 | ||
Type 2 diabetes | |||||||||
WESDR Moss 1993 | Prospective cohort | 4 | 674 | HbA1c, duration of DM, and DR severity at baseline | OR | 0.95 | 0.83 to 1.08 |
BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; DM: diabetes mellitus; DR: diabetic retinopathy; HbA1c: glycated haemoglobin/haemoglobin A1c; HR: hazard ratio; NPDR: non‐proliferative diabetic retinopathy; OR: odds ratio; PDR: proliferative diabetic retinopathy; RR: risk ratio; SBP: systolic blood pressure; vs: versus